In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations

被引:9
|
作者
Rezvani, Saba [1 ]
Ebadi, Ahmad [2 ]
Razzaghi-Asl, Nima [3 ]
机构
[1] Ardabil Univ Med Sci, Sch Pharm, Res Comm, Ardebil, Iran
[2] Hamadan Univ Med Sci, Med Plants & Nat Prod Res Ctr, Sch Pharm, Dept Med Chem, Hamadan, Hamadan, Iran
[3] Ardabil Univ Med Sci, Sch Pharm, Dept Med Chem, Ardebil 5618953141, Iran
来源
关键词
Cancer; Hsp90; inhibitors; molecular docking; induced fit; molecular dynamics; HEAT-SHOCK PROTEINS; SELECTIVE INHIBITORS; CHAPERONE HSP90; DISCOVERY; CANCER; HIT; HSP90-ALPHA/BETA; OPTIMIZATION; DESIGN; SERIES;
D O I
10.1080/07391102.2021.1947383
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular chaperone heat shock protein 90 (Hsp90) has emerged as one of the most exciting targets for anticancer drug development and Hsp90 inhibitors are potentially useful chemotherapeutic agents in cancer. Within the current study, Hsp90 inhibitors that entered different phases of clinical trials were subjected to Zinc15 structure query to find similar compounds (>= 78%). Obtained small molecules (1-29) with defined similarity cut-off were docked into ensemble of Hsp90-a NTDs. Docked complexes were ranked on the basis of binding modes and Gibbs free energies as Hsp90 binders (cutoff point; Delta G(b) <= -12 kcal/mol). Top-ranked compounds were subjected to energy decomposition analysis per residue of binding pocket via density functional theory (DFT) calculations in B3LYP level of theory. Subsequent MD simulations of the top-ranked complexes were performed for 100 ns to explore the stable binding modes during a reasonable period in explicit water. Results of molecular docking and intermolecular binding analysis indicated that H-bond, hydrophobic and salt bridge interactions were determinant forces in complex formation. Compounds 19 and 20 were well accommodated in binding pocket of Hsp90 via relatively varied conformations. It was revealed that Asn51 and Phe138 were key residues that interacted stably to 19 and 20. Although primary mechanism of action for proposed molecules are unknown and yet to be explored, results of the present study revealed key structural features for future structure-guided optimization toward potent inhibitors of Hsp90-alpha NTD.
引用
收藏
页码:10665 / 10676
页数:12
相关论文
共 50 条
  • [31] Dihydroxylphenyl amides as inhibitors of the Hsp90 molecular chaperone
    Kung, Pei-Pei
    Funk, Lee
    Meng, Jerry
    Collins, Michael
    Zhou, Joe Zhongxiang
    Johnson, M. Catherine
    Ekker, Anne
    Wang, Jeff
    Mehta, Pramod
    Yin, Min-Jean
    Rodgers, Caroline
    Davies, Jay F.
    Bayman, Eileen
    Smeal, Tod
    Maegley, Karen A.
    Gehring, Michael R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6273 - 6278
  • [32] Molecular Dynamics Simulations Reveal the Mechanisms of Allosteric Activation of Hsp90 by Designed Ligands
    Gerolamo Vettoretti
    Elisabetta Moroni
    Sara Sattin
    Jiahui Tao
    David A. Agard
    Anna Bernardi
    Giorgio Colombo
    Scientific Reports, 6
  • [33] Molecular Dynamics Simulations Reveal the Mechanisms of Allosteric Activation of Hsp90 by Designed Ligands
    Vettoretti, Gerolamo
    Moroni, Elisabetta
    Sattin, Sara
    Tao, Jiahui
    Agard, David A.
    Bernardi, Anna
    Colombo, Giorgio
    SCIENTIFIC REPORTS, 2016, 6
  • [34] Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors
    Mahmoud A. Al-Sha’er
    Mutasem O. Taha
    Journal of Molecular Modeling, 2012, 18 : 4843 - 4863
  • [35] Synthesis, DFT Study, Molecular Docking and Drug-Likeness Analysis of the New Hydrazine-1-Carbothioamide, Triazole and Thiadiazole Derivatives: Potential Inhibitors of HSP90
    Capan, Irfan
    Servi, Suleyman
    Yildirim, Ismail
    Sert, Yusuf
    CHEMISTRYSELECT, 2021, 6 (23): : 5838 - 5846
  • [36] Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors
    Al-Sha'er, Mahmoud A.
    Taha, Mutasem O.
    JOURNAL OF MOLECULAR MODELING, 2012, 18 (11) : 4843 - 4863
  • [37] Identification of potential PIM-2 inhibitors via ligand-based generative models, molecular docking and molecular dynamics simulations
    Qin, Tianli
    Wang, Yijian
    Kong, Miaomiao
    Zhong, Hongliang
    Wu, Tao
    Xi, Zixuan
    Qian, Zhenyong
    Li, Ke
    Cai, Yuepiao
    Wu, Jianzhang
    Li, Wulan
    MOLECULAR DIVERSITY, 2024, 28 (04) : 2245 - 2262
  • [38] Evolution of the conformational dynamics of the molecular chaperone Hsp90
    Riedl, Stefan
    Bilgen, Ecenaz
    Agam, Ganesh
    Hirvonen, Viivi
    Jussupow, Alexander
    Tippl, Franziska
    Riedl, Maximilian
    Maier, Andreas
    Becker, Christian F. W.
    Kaila, Ville R. I.
    Lamb, Don C.
    Buchner, Johannes
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [39] Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity
    Posfai, Dora
    Eubanks, Amber L.
    Keim, Allison I.
    Lu, Kuan-Yi
    Wang, Grace Z.
    Hughes, Philip F.
    Kato, Nobutaka
    Haystead, Timothy A.
    Derbyshire, Emily R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [40] Identification of new biomarkers for clinical trials of Hsp90 inhibitors
    Zhang, Hong
    Chung, Daun
    Yang, Yong-Ching
    Neely, Laura
    Tsururnoto, Steven
    Fan, Junhua
    Zhang, Lin
    Biamonte, Marco
    Brekken, John
    Lundgren, Karen
    Burrows, Francis
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (05) : 1256 - 1264